DS
RAIN

David Shaw’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

David Shaw’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,923
Closed -$238K – 5807
2021
Q3 		$238K Sell
15,923
-11,799
-43% -$201K ﹤0.01% 4489
2021
Q2 		$431K Buy
+27,722
New +$486K ﹤0.01% 4106

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

David Shaw's RAIN Position: Q4 2021 in Review

David Shaw sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2021, closing a stake of 15,923 shares — an estimated $238K sold.

David Shaw first reported a position in RAIN in Q2 2021 and held it in 2 quarters. The position peaked at $431K in Q2 2021. 41 funds tracked by Wall St. Rank hold RAIN as of Q4 2021.

  • David Shaw reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • David Shaw sold 15,923 Rain Oncology Inc. Common Stock shares in Q4 2021, an estimated $238K.
  • David Shaw first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • David Shaw's Rain Oncology Inc. Common Stock position peaked at $431K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.